Semir Paşa
YOU?
Author Swipe
View article: Evaluation of Prenatal Comfort, Sleep, and Quality of Life in Pregnant Women with Cholestasis: A Cross-Sectional Study
Evaluation of Prenatal Comfort, Sleep, and Quality of Life in Pregnant Women with Cholestasis: A Cross-Sectional Study Open
Background: Associated with adverse pregnancy outcomes, intrahepatic cholestasis of pregnancy is the most prevalent liver disease that women typically experience during pregnancy. This study aimed to evaluate prenatal comfort, sleep, and q…
View article: Laboratory evaluation of vasoreactivity; asymmetric dymethylarginine, nitric oxide, fibrinogen and high sensitive C-reactive protein in patients with polycystic ovary syndrome
Laboratory evaluation of vasoreactivity; asymmetric dymethylarginine, nitric oxide, fibrinogen and high sensitive C-reactive protein in patients with polycystic ovary syndrome Open
Background-Aim We aimed to compare of fibrinogen, high sensitivie C reactive protein (hsCRP), asymmetric dymethylarginine (ADMA) and nitric oxide (NO) levels as laboratory parameters of vasoreactivity in patients with PCOS. Material and Me…
View article: Evaluation inflammatory markers of hemogram parameters in primary ovarian insufficiency
Evaluation inflammatory markers of hemogram parameters in primary ovarian insufficiency Open
Inflammatory markers of hemogram detected higher in patients with POI then control subjects.
View article: Clinical characteristics of Crouzon syndrome
Clinical characteristics of Crouzon syndrome Open
Crouzon syndrome (CS) is an genetic disorder with autosomal dominant inheritance caused by mutation of the gene for fibroblast growth factor receptor 2 (FGFR2) was described as one of the varieties of craniosynostosis. In this presented ca…
View article: A Case of Orbital Granulocytic Sarcoma (Chloroma) Well Responded to the Treatment
A Case of Orbital Granulocytic Sarcoma (Chloroma) Well Responded to the Treatment Open
Granulocytic sarcoma (GS), myeloid sarcoma (MS) or extra medullary leukemic deposits is an unusual manifestation of AML, accounting for about 3% of acute leukaemia’s. GS may occur as a manifestation of a systemic myelogenic leukaemia or it…